Comments
Loading...

Hansa Biopharma (HNSBF) Stock Price, Quote, News & History

HNSBFOTCEM
Logo brought to you by Benzinga Data
$2.91
At close: Dec 16, 4:00 PM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 14.51K
Day Range
- - -
52 Wk Range
2.73 - 4.58
Market Cap
$290.20M
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
999.99

Recent Hansa Biopharma AB News

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 14.51K
Day Range
- - -
52 Wk Range
2.73 - 4.58
Market Cap
$290.20M
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
999.99

About

Sector
Health Care
Industry
Biotechnology
Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidat...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HNSBF

FAQ

Q

How do I buy Hansa Biopharma (HNSBF) stock?

A

You can purchase shares of Hansa Biopharma (OTCEM:HNSBF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Hansa Biopharma (HNSBF) competitors?

A

There are no as such competitors for Hansa Biopharma.

Q

What is the forecast, or price target, for Hansa Biopharma (HNSBF) stock?

A

There is no analysis for Hansa Biopharma to provide a consensus price target.

Q

What is the current price for Hansa Biopharma (HNSBF)?

A

The stock price for Hansa Biopharma (OTCEM: HNSBF) is $2.91 last updated November 6, 2025 at 11:17 AM EST.

Q

Does Hansa Biopharma (HNSBF) pay a dividend?

A

There are no upcoming dividends for Hansa Biopharma.

Q

When is Hansa Biopharma (OTCEM:HNSBF) reporting earnings?

A

Hansa Biopharma does not have any upcoming earnings scheduled.

Q

Is Hansa Biopharma (HNSBF) going to split?

A

There is no upcoming split for Hansa Biopharma.

Q

What sector and industry does Hansa Biopharma (HNSBF) operate in?

A

Hansa Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.